NEW YORK STOCK EXCHANGE, INC. · JNJ
-2.37% · -$5.47
Johnson & Johnson

Johnson & Johnson

Pharmaceuticals
$225.33
Veridion Score
BETAHIGH CONF · 5/6 factors
As of May 31, 8:56 PM EDT · JNJ
Methodology
57/100
NEUTRAL

Composite intelligence score across six weighted factors. Higher score = stronger composite signal.

Score history: Coverage building
Institutional Flow · 90D
Corporate Insiders
SEC Form 4
64/ 100
+140K net shares (90d) · 15B / 1S
US Congress
Senate eFD + House STOCK Act
/ 100
no data
Wall Street Analysts
Sell-side consensus
70/ 100
6 SB · 14 B · 12 H
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Insider · Congress · Wall Street flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 5/6 factors with data · Computed May 31, 8:56 PM EDT · Refreshes hourly
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
BETA

Why is JNJ moving today?

Analyzing news articles + insider activity + analyst signals…
About Johnson & Johnson
PHARMACEUTICAL PREPARATIONS
Founded
Listed
1944
Employees
141K
HQ
US

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Open
$231.23
Previous close
$230.80
Day high
$231.50
Day low
$224.59
Market cap
$542.42B
IPO
1944-09-25
Country
US
Currency
USD
Data ledger
Quote and day range
As of May 29, 4:00 PM EDT
Source: Market data
Veridion Score
As of May 31, 8:56 PM EDT
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
Insider activity · 6M
Loading Form 4 filings…
Congress · 90D
Loading PTR filings…
Federal contracts

JNJ contract awards, year to date.

Public federal awards linked to this ticker.

$249.4K
Refresh interval: 12hSource: Federal contract awards
Department of Veterans Affairs
$133.5K
PURCHASE 2 NGEN CARTO3 MAPPING SYSTEMS FOR TVHS NASHVILLE

PURCHASE 2 NGEN CARTO3 MAPPING SYSTEMS FOR TVHS NASHVILLE

Apr 20, 2026
Department of Veterans Affairs
$56.5K
MANDIBLE IMPLANT

MANDIBLE IMPLANT

Apr 5, 2026
Department of Health and Human Services
$34.8K
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC

JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC:1106694 [26-002571]

Mar 18, 2026
Department of Veterans Affairs
$24.6K
LAPAROSCOPIC

LAPAROSCOPIC

Apr 20, 2026
Lobbying spend

JNJ lobbying filings, year to date.

Registered lobbying filings matched to Johnson & Johnson.

$5.3M
Refresh interval: 12hSource: LDA disclosure filings
Health Issues Budget/Appropriations Copyright/Patent/Trademark Law Enforcement/Crime/Criminal Justice Pharmacy Science/Technology Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)Health IssuesHealth Issues Medicare/Medicaid Taxation/Internal Revenue Code Bankruptcy Trade (domestic/foreign)
Filing
$3.5M
JOHNSON & JOHNSON SERVICES INC

JOHNSON & JOHNSON SERVICES, INC.

Apr 20, 2026
Filing
$1.5M
JOHNSON & JOHNSON SERVICES INC

JOHNSON & JOHNSON SERVICES, INC.

Jan 20, 2026
Filing
$100.0K
JOHNSON & JOHNSON SERVICES INC.

TODD STRATEGY GROUP

Apr 20, 2026
Latest news · JNJ
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Loading consensus…
Options · Live
Loading options chain…
Related tickers

Cross-references from this score page.

Apprentice · 1 rail
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.